{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:17:55Z","timestamp":1780143475613,"version":"3.54.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms8369","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T12:10:55Z","timestamp":1434456655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["\u03b2-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling"],"prefix":"10.1038","volume":"6","author":[{"given":"Yidong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-908X","authenticated-orcid":false,"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"BFncomms8369_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner, A., Llovet, J. M. & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245\u20131255 (2012).","journal-title":"Lancet"},{"key":"BFncomms8369_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197\u2013208 (2010).","journal-title":"Cell"},{"key":"BFncomms8369_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"BFncomms8369_CR4","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557\u20132576 (2007).","journal-title":"Gastroenterology"},{"key":"BFncomms8369_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","volume":"56","author":"B Sun","year":"2012","unstructured":"Sun, B. & Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704\u2013713 (2012).","journal-title":"J. Hepatol."},{"key":"BFncomms8369_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","volume":"155","author":"G He","year":"2013","unstructured":"He, G. et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384\u2013396 (2013).","journal-title":"Cell"},{"key":"BFncomms8369_CR7","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00432-013-1455-8","volume":"139","author":"H Fujiki","year":"2013","unstructured":"Fujiki, H., Sueoka, E. & Suganuma, M. Tumor promoters: from chemicals to inflammatory proteins. J. Cancer Res. Clin. Oncol. 139, 1603\u20131614 (2013).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"BFncomms8369_CR8","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1111\/j.1440-1746.2006.04645.x","volume":"22","author":"E Hatano","year":"2007","unstructured":"Hatano, E. Tumor necrosis factor signaling in hepatocyte apoptosis. J. Gastroenterol. Hepatol. 22, (Suppl 1): S43\u2013S44 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFncomms8369_CR9","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/carcin\/bgs249","volume":"33","author":"L Xia","year":"2012","unstructured":"Xia, L. et al. The TNF-alpha\/ROS\/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis 33, 2250\u20132259 (2012).","journal-title":"Carcinogenesis"},{"key":"BFncomms8369_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cell.2012.12.021","volume":"152","author":"J Yan","year":"2013","unstructured":"Yan, J. et al. Inactivation of BAD by IKK inhibits TNFalpha-induced apoptosis independently of NF-kappaB activation. Cell 152, 304\u2013315 (2013).","journal-title":"Cell"},{"key":"BFncomms8369_CR11","doi-asserted-by":"publisher","first-page":"G1357","DOI":"10.1152\/ajpgi.2001.281.6.G1357","volume":"281","author":"E Hatano","year":"2001","unstructured":"Hatano, E. & Brenner, D. A. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1357\u2013G1368 (2001).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFncomms8369_CR12","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1073\/pnas.051042298","volume":"98","author":"ON Ozes","year":"2001","unstructured":"Ozes, O. N. et al. A phosphatidylinositol 3-kinase\/Akt\/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl Acad. Sci. USA 98, 4640\u20134645 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms8369_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","volume":"149","author":"CH Chan","year":"2012","unstructured":"Chan, C. H. et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149, 1098\u20131111 (2012).","journal-title":"Cell"},{"key":"BFncomms8369_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","volume":"140","author":"DF Calvisi","year":"2011","unstructured":"Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140, 1071\u20131083 (2011).","journal-title":"Gastroenterology"},{"key":"BFncomms8369_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"C Ho","year":"2012","unstructured":"Ho, C. et al. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)\/SKP2, and c-Myc pathways. Hepatology 55, 833\u2013845 (2012).","journal-title":"Hepatology"},{"key":"BFncomms8369_CR16","doi-asserted-by":"publisher","first-page":"e54595","DOI":"10.1371\/journal.pone.0054595","volume":"8","author":"A Cuconati","year":"2013","unstructured":"Cuconati, A. et al. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells. PLoS ONE 8, e54595 (2013).","journal-title":"PLoS ONE"},{"key":"BFncomms8369_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/CIRCRESAHA.110.231126","volume":"109","author":"HA Rockman","year":"2011","unstructured":"Rockman, H. A. & Lefkowitz, R. J. Introduction to the series on novel aspects of cardiovascular G-protein-coupled receptor signaling. Circ. Res. 109, 202\u2013204 (2011).","journal-title":"Circ. Res."},{"key":"BFncomms8369_CR18","first-page":"4997","volume":"42","author":"WT Chen","year":"2013","unstructured":"Chen, W. T. et al. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN. Oncogene 42, 4997\u20135005 (2013).","journal-title":"Oncogene"},{"key":"BFncomms8369_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","volume":"17","author":"EJ Whalen","year":"2011","unstructured":"Whalen, E. J., Rajagopal, S. & Lefkowitz, R.,J. Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists. Trends Mol. Med. 17, 126\u2013139 (2011).","journal-title":"Trends Mol. Med."},{"key":"BFncomms8369_CR20","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1124\/mol.105.016857","volume":"69","author":"ND Khoa","year":"2006","unstructured":"Khoa, N. D., Postow, M., Danielsson, J. & Cronstein, B. N. Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Mol. Pharmacol. 69, 1311\u20131319 (2006).","journal-title":"Mol. Pharmacol."},{"key":"BFncomms8369_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1189\/jlb.0107051","volume":"82","author":"J Lattin","year":"2007","unstructured":"Lattin, J. et al. G-protein-coupled receptor expression, function, and signaling in macrophages. J. Leukoc. Biol. 82, 16\u201332 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"BFncomms8369_CR22","doi-asserted-by":"publisher","first-page":"e50787","DOI":"10.1371\/journal.pone.0050787","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese. PLoS ONE 7, e50787 (2012).","journal-title":"PLoS ONE"},{"key":"BFncomms8369_CR23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11033-012-2148-0","volume":"40","author":"S Hu","year":"2013","unstructured":"Hu, S. et al. Involvement of beta-arrestins in cancer progression. Mol. Biol. Rep. 40, 1065\u20131071 (2013).","journal-title":"Mol. Biol. Rep."},{"key":"BFncomms8369_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1096\/fj.07-9046com","volume":"22","author":"L Zou","year":"2008","unstructured":"Zou, L., Yang, R., Chai, J. & Pei, G. Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J. 22, 355\u2013364 (2008).","journal-title":"FASEB J."},{"key":"BFncomms8369_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","volume":"69","author":"SM DeWire","year":"2007","unstructured":"DeWire, S. M., Ahn, S., Lefkowitz, R. J. & Shenoy, S. K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483\u2013510 (2007).","journal-title":"Annu. Rev. Physiol."},{"key":"BFncomms8369_CR26","doi-asserted-by":"publisher","first-page":"19839","DOI":"10.1073\/pnas.1117444108","volume":"108","author":"G Schulte","year":"2011","unstructured":"Schulte, G. & Shenoy, S. K. beta-Arrestin and dishevelled coordinate biased signaling. Proc. Natl Acad. Sci. USA 108, 19839\u201310840 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms8369_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.24516","volume":"54","author":"W Qiu","year":"2011","unstructured":"Qiu, W. et al. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology 54, 1249\u20131258 (2011).","journal-title":"Hepatology"},{"key":"BFncomms8369_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature10368","volume":"477","author":"MR Hara","year":"2011","unstructured":"Hara, M. R. et al. A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477, 349\u2013353 (2011).","journal-title":"Nature"},{"key":"BFncomms8369_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1189\/jlb.0506297","volume":"80","author":"A Budhu","year":"2006","unstructured":"Budhu, A. & Wang, X. W. The role of cytokines in hepatocellular carcinoma. J. Leukoc. Biol. 80, 1197\u20131213 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"BFncomms8369_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cyto.2009.11.020","volume":"49","author":"A Kassardjian","year":"2010","unstructured":"Kassardjian, A., Dakroub, Z., Zein, O. E. & Kreydiyyeh, S. I. Signaling pathway underlying the up-regulatory effect of TNF-alpha on the Na(+)\/K(+) ATPase in HepG2 cells. Cytokine 49, 312\u2013318 (2010).","journal-title":"Cytokine"},{"key":"BFncomms8369_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"Lin, W. W. & Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175\u20131183 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFncomms8369_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3748\/wjg.v17.i1.111","volume":"17","author":"Y Diao","year":"2011","unstructured":"Diao, Y., Zhao, X. F., Lin, J. S., Wang, Q. Z. & Xu, R. A. Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid. World J. Gastroenterol. 17, 111\u2013117 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFncomms8369_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/sj.leu.2404784","volume":"21","author":"CT Storlazzi","year":"2007","unstructured":"Storlazzi, C. T. et al. Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. Leukemia 21, 2221\u20132225 (2007).","journal-title":"Leukemia"},{"key":"BFncomms8369_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.prp.2010.10.007","volume":"15","author":"H Kai","year":"2011","unstructured":"Kai, H. et al. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma. Pathol. Res. Pract. 15, 43\u201348 (2011).","journal-title":"Pathol. Res. Pract."},{"key":"BFncomms8369_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/1476-4598-9-289","volume":"9","author":"SB Hooks","year":"2010","unstructured":"Hooks, S. B. et al. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Mol. Cancer 9, 289 (2010).","journal-title":"Mol. Cancer"},{"key":"BFncomms8369_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/B978-0-12-394440-5.00015-2","volume":"118","author":"PM Sobolesky","year":"2013","unstructured":"Sobolesky, P. M. & Moussa, O. The role of beta-arrestins in cancer. Prog. Mol. Biol. Transl. Sci. 118, 395\u2013411 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"BFncomms8369_CR37","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.1109457109","volume":"109","author":"C Bonnans","year":"2012","unstructured":"Bonnans, C. et al. Essential requirement for beta-arrestin2 in mouse intestinal tumors with elevated Wnt signaling. Proc. Natl Acad. Sci. USA 109, 3047\u20133052 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms8369_CR38","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-14-0681","volume":"75","author":"S Pillai","year":"2015","unstructured":"Pillai, S. et al. beta-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition. Cancer Res. 75, 1009\u20131020 (2015).","journal-title":"Cancer Res."},{"key":"BFncomms8369_CR39","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.3748\/wjg.v19.i30.4925","volume":"19","author":"Q Yang","year":"2013","unstructured":"Yang, Q. et al. Tumor necrosis factor-alpha mediates JNK activation response to intestinal ischemia-reperfusion injury. World J. Gastroenterol. 19, 4925\u20134934 (2013).","journal-title":"World J. Gastroenterol."},{"key":"BFncomms8369_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.devcel.2009.09.011","volume":"17","author":"JJ Kovacs","year":"2009","unstructured":"Kovacs, J. J., Hara, M. R., Davenport, C. L., Kim, J. & Lefkowitz, R. J. Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev. Cell 17, 443\u2013458 (2009).","journal-title":"Dev. Cell"},{"key":"BFncomms8369_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cncr.20774","volume":"103","author":"K Nakanishi","year":"2005","unstructured":"Nakanishi, K., Sakamoto, M., Yamasaki, S., Todo, S. & Hirohashi, S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 103, 307\u2013312 (2005).","journal-title":"Cancer"},{"key":"BFncomms8369_CR42","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/ni1489","volume":"8","author":"Y Shi","year":"2007","unstructured":"Shi, Y. et al. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat. Immunol. 8, 817\u2013824 (2007).","journal-title":"Nat. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms8369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms8369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms8369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T11:25:04Z","timestamp":1672917904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms8369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,3]]}},"alternative-id":["BFncomms8369"],"URL":"https:\/\/doi.org\/10.1038\/ncomms8369","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"2 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7369"}}